ROIV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.80%

Insider Buying (Last 12 Months): $49,957.05

Insider Selling (Last 12 Months): $396,992,676.11

Roivant Sciences Insider Trading History Chart

Roivant Sciences Share Price & Price History

^$21.97

▲ +0.03 (0.14%)

As of 02/3/2026 05:00 PM ET

Days: 30 | 90 | 365

Roivant Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/12/2026	Eric Venker	CEO	Sell	200,000	$21.92	$4,384,000.00	1,654,597
12/31/2025	Mayukh Sukhatme	Insider	Sell	1,018,995	$21.71	$22,122,381.45	20,267,429
12/29/2025	Mayukh Sukhatme	Insider	Sell	311,873	$21.74	$6,780,119.02	19,273,032
12/24/2025	Eric Venker	CEO	Sell	75,000	$22.53	$1,689,750.00	1,654,597
12/23/2025	Eric Venker	CEO	Sell	200,000	$22.45	$4,490,000.00	1,611,749
12/23/2025	Richard Pulik	CFO	Sell	406,731	$22.43	$9,122,976.33	239,413
12/17/2025	Daniel Allen Gold	Director	Sell	777,332	$23.07	$17,933,049.24	16,353,113
12/17/2025	Mayukh Sukhatme	Insider	Sell	26,831	$23.09	$619,527.79	18,869,229
12/16/2025	Daniel Allen Gold	Director	Sell	917,282	$23.04	$21,134,177.28	17,130,445
12/15/2025	Matthew Gline	CEO	Sell	1,740,000	$21.68	$37,723,200.00	17,290,820
12/15/2025	Vivek Ramaswamy	Major Shareholder	Sell	353,745	$22.05	$7,800,077.25	34,132,463
12/12/2025	Vivek Ramaswamy	Major Shareholder	Sell	1,975,858	$21.96	$43,389,841.68	36,350,621
12/11/2025	Vivek Ramaswamy	Major Shareholder	Sell	774,142	$21.64	$16,752,432.88	34,749,305
12/9/2025	Eric Venker	CEO	Sell	200,000	$20.85	$4,170,000.00	1,497,908
11/19/2025	Daniel Allen Gold	Director	Sell	1,300,000	$20.23	$26,299,000.00	18,047,727
11/17/2025	Vivek Ramaswamy	Major Shareholder	Sell	539,650	$20.51	$11,068,221.50	33,653,756
11/14/2025	Vivek Ramaswamy	Major Shareholder	Sell	1,027,670	$20.33	$20,892,531.10	34,193,406
11/13/2025	Vivek Ramaswamy	Major Shareholder	Sell	287,283	$20.81	$5,978,359.23	35,221,076
11/7/2025	Eric Venker	CEO	Sell	200,000	$20.22	$4,044,000.00	1,504,959
10/17/2025	Eric Venker	CEO	Sell	118,418	$17.06	$2,020,211.08	1,504,959
10/16/2025	Eric Venker	CEO	Sell	318,282	$17.05	$5,426,708.10	1,504,959
10/15/2025	Eric Venker	CEO	Sell	414,683	$16.93	$7,020,583.19	1,504,959
10/13/2025	Eric Venker	CEO	Sell	20,727	$16.25	$336,813.75	1,504,959
10/9/2025	Eric Venker	CEO	Sell	104,940	$16.30	$1,710,522.00	1,504,959
10/8/2025	Eric Venker	CEO	Sell	138,602	$16.20	$2,245,352.40	1,504,959
10/7/2025	Eric Venker	CEO	Sell	355,161	$16.15	$5,735,850.15	1,504,959
10/6/2025	Eric Venker	CEO	Sell	171,396	$16.34	$2,800,610.64	1,504,959
9/23/2025	Eric Venker	CEO	Sell	611,000	$14.83	$9,061,130.00	1,504,959
9/22/2025	Eric Venker	CEO	Sell	416,182	$14.99	$6,238,568.18	2,115,959
9/19/2025	Eric Venker	CEO	Sell	683,818	$14.95	$10,223,079.10	1,969,767
9/18/2025	Matthew Gline	CEO	Buy	3,315	$15.07	$49,957.05	17,287,081
9/5/2025	Vivek Ramaswamy	Major Shareholder	Sell	385,816	$12.96	$5,000,175.36	35,508,359
9/4/2025	Vivek Ramaswamy	Major Shareholder	Sell	194,933	$12.92	$2,518,534.36	35,894,175
9/3/2025	Vivek Ramaswamy	Major Shareholder	Sell	1,195,000	$12.50	$14,937,500.00	36,089,108
8/20/2025	Eric Venker	CEO	Sell	100,000	$11.72	$1,172,000.00	1,653,585
7/21/2025	Eric Venker	CEO	Sell	100,000	$11.52	$1,152,000.00	1,462,223
6/20/2025	Eric Venker	COO	Sell	100,000	$11.45	$1,145,000.00	1,462,223
6/20/2025	Vivek Ramaswamy	Major Shareholder	Sell	577,007	$11.46	$6,612,500.22	37,284,108
6/18/2025	Vivek Ramaswamy	Major Shareholder	Sell	565,266	$11.45	$6,472,295.70	37,861,115
6/6/2025	Vivek Ramaswamy	Major Shareholder	Sell	200,800	$11.19	$2,246,952.00	38,426,381
6/4/2025	Vivek Ramaswamy	Major Shareholder	Sell	547,430	$11.34	$6,207,856.20	38,627,181
6/3/2025	Eric Venker	COO	Sell	566,278	$11.22	$6,353,639.16	1,462,223
6/2/2025	Eric Venker	COO	Sell	433,722	$11.07	$4,801,302.54	1,243,475
5/20/2025	Eric Venker	COO	Sell	100,000	$10.95	$1,095,000.00	1,077,197
5/6/2025	Vivek Ramaswamy	Major Shareholder	Sell	273,959	$11.47	$3,142,309.73	39,799,611
4/21/2025	Eric Venker	COO	Sell	100,000	$10.22	$1,022,000.00	1,116,345
3/24/2025	Eric Venker	COO	Sell	434,478	$10.82	$4,701,051.96	1,127,290
3/20/2025	Eric Venker	COO	Sell	315,522	$11.06	$3,489,673.32	959,457
2/20/2025	Eric Venker	COO	Sell	100,000	$10.65	$1,065,000.00	896,869
2/13/2025	Eric Venker	COO	Sell	218,041	$10.42	$2,271,987.22	896,869
2/13/2025	Rakhi Kumar	CAO	Sell	227,500	$10.43	$2,372,825.00	163,264
1/21/2025	Eric Venker	COO	Sell	100,000	$11.28	$1,128,000.00	732,294
1/13/2025	Sciences Ltd. Roivant	Director	Buy	16,845,010	$20.00	$336,900,200.00	96,650,341
12/30/2024	Eric Venker	COO	Sell	177,704	$11.54	$2,050,704.16	740,976
12/27/2024	Eric Venker	COO	Sell	176,900	$11.82	$2,090,958.00	668,680
12/26/2024	Mayukh Sukhatme	CIO	Sell	689,495	$12.01	$8,280,834.95	18,836,547
12/24/2024	Mayukh Sukhatme	CIO	Sell	185,946	$12.00	$2,231,352.00	18,836,547
12/20/2024	Eric Venker	COO	Sell	100,000	$11.49	$1,149,000.00	595,580
12/18/2024	Mayukh Sukhatme	CIO	Sell	412,584	$12.05	$4,971,637.20	18,836,547
11/20/2024	Eric Venker	COO	Sell	100,000	$11.32	$1,132,000.00	606,525
10/21/2024	Eric Venker	COO	Sell	100,000	$11.65	$1,165,000.00	617,470
9/26/2024	Financial Lp Qvt	Director	Sell	876,000	$11.82	$10,354,320.00	22,179,358
9/24/2024	Keith S. Manchester	Director	Sell	368,052	$11.62	$4,276,764.24	1,412,126
9/23/2024	Matthew Gline	CEO	Sell	1,983,257	$11.79	$23,382,600.03	17,870,543
9/23/2024	Rakhi Kumar	CAO	Sell	250,000	$11.89	$2,972,500.00	209,322
2/9/2024	Eric Venker	COO	Sell	96,950	$10.92	$1,058,694.00	532,207
1/2/2024	Vivek Ramaswamy	Major Shareholder	Sell	3,000,000	$11.05	$33,150,000.00	51,929,426
10/5/2023	Eric Venker	COO	Sell	153,027	$10.11	$1,547,102.97	595,397
10/2/2023	Eric Venker	COO	Sell	440,752	$10.80	$4,760,121.60	595,397
10/2/2023	Sciences Ltd. Roivant	Director	Buy	1,526,316	$38.00	$58,000,008.00	79,805,331
9/28/2023	Keith S. Manchester	Director	Sell	6,896,144	$11.55	$79,650,463.20	5,023,787
9/28/2023	Svf Investments (Uk) Ltd	Major Shareholder	Sell	10,000,000	$12.60	$126,000,000.00	73,031,667
9/27/2023	Eric Venker	COO	Sell	500,000	$13.02	$6,510,000.00	595,397
9/8/2023	Eric Venker	COO	Sell	106,430	$12.19	$1,297,381.70	611,813
9/8/2023	Rakhi Kumar	CAO	Sell	99,350	$12.18	$1,210,083.00	197,950
9/6/2023	Eric Venker	COO	Sell	5,926	$11.85	$70,223.10	611,813
9/5/2023	Rakhi Kumar	CAO	Sell	1,724	$12.00	$20,688.00	197,950
9/1/2023	Eric Venker	COO	Sell	14,763	$11.90	$175,679.70	611,813
8/14/2023	Eric Venker	COO	Sell	59,811	$11.89	$711,152.79	627,918
8/3/2023	Rakhi Kumar	CAO	Sell	3,681	$12.00	$44,172.00	199,328
8/2/2023	Eric Venker	COO	Sell	16,397	$11.86	$194,468.42	627,918
8/1/2023	Rakhi Kumar	CAO	Sell	336	$12.00	$4,032.00	199,328
7/31/2023	Eric Venker	COO	Sell	117,372	$11.91	$1,397,900.52	627,918
7/26/2023	Eric Venker	COO	Sell	73,568	$10.91	$802,626.88	627,918
7/24/2023	Eric Venker	COO	Sell	33,081	$10.93	$361,575.33	644,215
7/21/2023	Eric Venker	COO	Sell	181,998	$11.13	$2,025,637.74	644,215
7/18/2023	Rakhi Kumar	CAO	Sell	100	$12.00	$1,200.00	82,128
7/14/2023	Rakhi Kumar	CAO	Sell	535	$12.00	$6,420.00	82,128
6/22/2023	Global Investors Lp Viking	Major Shareholder	Sell	13,000,000	$9.90	$128,700,000.00	641,010
6/9/2023	Eric Venker	COO	Sell	299,384	$9.91	$2,966,895.44	660,097
6/9/2023	Rakhi Kumar	CAO	Sell	43,893	$9.93	$435,857.49	198,582
6/7/2023	Eric Venker	COO	Sell	201	$9.85	$1,979.85	660,097
5/23/2023	Eric Venker	COO	Sell	415	$9.85	$4,087.75	675,768
5/8/2023	Eric Venker	COO	Sell	61,206	$8.93	$546,569.58	675,768
5/4/2023	Eric Venker	COO	Sell	88,838	$8.30	$737,355.40	675,768
5/2/2023	Eric Venker	COO	Sell	109,074	$8.29	$904,223.46	675,768
5/2/2023	Rakhi Kumar	CAO	Sell	15,517	$8.42	$130,653.14	200,139
4/28/2023	Rakhi Kumar	CAO	Sell	71,989	$8.47	$609,746.83	200,139
4/27/2023	Eric Venker	COO	Sell	73,514	$8.51	$625,604.14	675,768
4/26/2023	Rakhi Kumar	CAO	Sell	87,830	$8.68	$762,364.40	200,139
3/20/2023	Svf Investments (Uk) Ltd	Major Shareholder	Sell	12,000,000	$8.00	$96,000,000.00	83,031,667
3/1/2023	Richard Pulik	CFO	Sell	1,912	$8.08	$15,448.96	223,347
2/22/2023	Vivek Ramaswamy	Director	Sell	4,000,000	$7.95	$31,800,000.00	54,409,211

SEC Filings (Institutional Ownership Changes) for Roivant Sciences (NASDAQ:ROIV)

64.76% of Roivant Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Roivant Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/3/2026	Crossmark Global Holdings Inc.	25,607	$0.56M	0.0%	+12.5%	0.004%
2/3/2026	Anfield Capital Management LLC	118,951	$2.58M	0.8%	-23.6%	0.017%
2/3/2026	Pier Capital LLC	391,061	$8.49M	1.4%	-0.9%	0.056%
2/3/2026	Sequoia Financial Advisors LLC	11,615	$0.25M	0.0%	N/A	0.002%
2/3/2026	Credit Industriel ET Commercial	150,000	$3.26M	0.3%	-3.2%	0.022%
2/3/2026	Mitsubishi UFJ Asset Management Co. Ltd.	8,527	$0.19M	0.0%	-45.5%	0.001%
2/3/2026	SBI Securities Co. Ltd.	1,233	$27K	0.0%	+1,740.3%	0.000%
2/2/2026	Truist Financial Corp	21,406	$0.47M	0.0%	N/A	0.003%
2/2/2026	Sandro Wealth Management LLC	90,267	$1.96M	1.6%	N/A	0.013%
2/2/2026	Horizon Investments LLC	5,768	$0.13M	0.0%	N/A	0.001%
2/2/2026	Fifth Third Bancorp	4,310	$94K	0.0%	+15.8%	0.001%
1/30/2026	New York State Teachers Retirement System	270,221	$5.86M	0.0%	+5.6%	0.039%
1/30/2026	Jennison Associates LLC	2,353,386	$51.07M	0.0%	N/A	0.338%
1/30/2026	State of New Jersey Common Pension Fund D	135,303	$2.94M	0.0%	-24.9%	0.019%
1/30/2026	M&T Bank Corp	13,290	$0.29M	0.0%	N/A	0.002%
1/29/2026	Pictet Asset Management Holding SA	2,312,436	$50.18M	0.0%	+790.3%	0.332%
1/29/2026	State of Michigan Retirement System	103,500	$2.25M	0.0%	+1.1%	0.015%
1/29/2026	UBS Group AG	18,390,792	$399.08M	0.1%	+570.0%	2.644%
1/29/2026	Teachers Retirement System of The State of Kentucky	125,240	$2.72M	0.0%	+16.2%	0.018%
1/29/2026	Vanguard Group Inc.	42,059,041	$912.68M	0.0%	+8.4%	6.047%
1/29/2026	Impax Asset Management Group plc	550,000	$11.94M	0.1%	-69.4%	0.079%
1/29/2026	Concurrent Investment Advisors LLC	22,247	$0.48M	0.0%	N/A	0.003%
1/29/2026	China Universal Asset Management Co. Ltd.	129,330	$2.81M	0.2%	+8.0%	0.019%
1/28/2026	Arizona State Retirement System	105,685	$2.29M	0.0%	+16.7%	0.015%
1/28/2026	Legacy Capital Group California Inc.	21,162	$0.46M	0.1%	N/A	0.003%
1/28/2026	West Michigan Advisors LLC	29,079	$0.63M	0.1%	N/A	0.004%
1/28/2026	Kingswood Wealth Advisors LLC	12,206	$0.27M	0.0%	N/A	0.002%
1/28/2026	M&T Bank Corp	420,384	$9.12M	0.0%	N/A	0.060%
1/28/2026	Universal Beteiligungs und Servicegesellschaft mbH	80,561	$1.75M	0.0%	+90.9%	0.012%
1/27/2026	Evergreen Capital Management LLC	10,000	$0.22M	0.0%	N/A	0.001%
1/27/2026	Zurcher Kantonalbank Zurich Cantonalbank	131,860	$2.86M	0.0%	+15.6%	0.019%
1/27/2026	Asset Management One Co. Ltd.	6,168	$0.13M	0.0%	N/A	0.001%
1/27/2026	GF Fund Management CO. LTD.	13,668	$0.30M	0.0%	-7.0%	0.002%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	35,493	$0.77M	0.0%	+34.4%	0.005%
1/26/2026	CWM LLC	11,833	$0.26M	0.0%	+281.1%	0.002%
1/26/2026	KBC Group NV	12,534	$0.27M	0.0%	+17.5%	0.002%
1/26/2026	Consolidated Portfolio Review Corp	276,530	$6M	0.5%	N/A	0.040%
1/23/2026	Farther Finance Advisors LLC	3,600	$78K	0.0%	+59.6%	0.001%
1/23/2026	State of Alaska Department of Revenue	43,352	$0.94M	0.0%	-5.6%	0.006%
1/23/2026	Forefront Wealth Management Inc.	9,622	$0.21M	0.1%	N/A	0.001%
1/23/2026	Elevate Capital Advisors LLC	77,545	$1.68M	1.1%	-31.8%	0.011%
1/21/2026	Yousif Capital Management LLC	139,552	$3.21M	0.0%	+1.0%	0.020%
1/21/2026	Capricorn Fund Managers Ltd	445,500	$9.67M	2.3%	+124.4%	0.064%
1/16/2026	Penn Davis Mcfarland Inc.	1,858,289	$40.33M	3.9%	-0.2%	0.267%
1/16/2026	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	9,242	$0.20M	0.0%	N/A	0.001%
1/15/2026	Burns Matteson Capital Management LLC	17,612	$0.38M	0.1%	N/A	0.003%
1/15/2026	Fifth Third Wealth Advisors LLC	9,721	$0.21M	0.0%	N/A	0.001%
1/15/2026	Retirement Systems of Alabama	525,863	$11.41M	0.0%	+1.1%	0.076%
1/14/2026	Exchange Traded Concepts LLC	250,468	$5.44M	0.0%	N/A	0.036%
1/9/2026	SG Americas Securities LLC	23,294	$0.51M	0.0%	-53.6%	0.003%
1/9/2026	Assenagon Asset Management S.A.	6,937,112	$150.54M	0.2%	+11,507.5%	0.997%
1/8/2026	Wealth Enhancement Advisory Services LLC	19,050	$0.41M	0.0%	N/A	0.003%
1/8/2026	Wedmont Private Capital	15,462	$0.34M	0.0%	+17.0%	0.002%
1/5/2026	GAMMA Investing LLC	11,039	$0.24M	0.0%	+18.7%	0.002%
12/2/2025	Allworth Financial LP	1,795	$27K	0.0%	+48.1%	0.000%
12/2/2025	Swiss Life Asset Management Ltd	14,375	$0.22M	0.0%	N/A	0.002%
11/19/2025	Danske Bank A S	9,100	$0.14M	0.0%	N/A	0.001%
11/17/2025	Woodline Partners LP	3,065,590	$46.38M	0.2%	-23.4%	0.449%
11/17/2025	PDT Partners LLC	617,462	$9.34M	0.6%	-22.4%	0.090%
11/17/2025	XTX Topco Ltd	70,519	$1.07M	0.1%	N/A	0.010%
11/17/2025	Alyeska Investment Group L.P.	494,455	$7.48M	0.0%	+326.7%	0.072%
11/17/2025	Utah Retirement Systems	20,626	$0.31M	0.0%	+3.0%	0.003%
11/17/2025	Voleon Capital Management LP	96,573	$1.46M	0.0%	N/A	0.014%
11/17/2025	Voloridge Investment Management LLC	2,281,123	$34.51M	0.1%	N/A	0.334%
11/17/2025	Verition Fund Management LLC	629,497	$9.52M	0.0%	+26.3%	0.092%
11/17/2025	Scientech Research LLC	50,860	$0.77M	0.3%	N/A	0.007%
11/17/2025	SB Investment Advisers UK Ltd.	40,315,127	$609.97M	4.6%	-32.8%	5.904%
11/17/2025	Sherbrooke Park Advisers LLC	14,634	$0.22M	0.1%	N/A	0.002%
11/17/2025	Polar Capital Holdings Plc	1,958,735	$29.64M	0.1%	+59.9%	0.287%
11/17/2025	Prelude Capital Management LLC	81,080	$1.23M	0.1%	-50.8%	0.012%
11/17/2025	Public Employees Retirement System of Ohio	121,796	$1.84M	0.0%	+3.5%	0.018%
11/17/2025	Northern Trust Corp	3,283,061	$49.67M	0.0%	+1.5%	0.481%
11/17/2025	Mariner LLC	72,382	$1.10M	0.0%	N/A	0.011%
11/17/2025	Millennium Management LLC	2,588,098	$39.16M	0.0%	+167.9%	0.379%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	23,953	$0.36M	0.0%	-17.0%	0.004%
11/17/2025	HighVista Strategies LLC	98,858	$1.50M	0.4%	+61.4%	0.014%
11/17/2025	Gotham Asset Management LLC	330,475	$5M	0.0%	+744.1%	0.048%
11/17/2025	Foursixthree Capital LP	938,175	$14.20M	3.9%	+4.2%	0.137%
11/17/2025	Elevation Point Wealth Partners LLC	29,659	$0.45M	0.0%	N/A	0.004%
11/17/2025	Bamco Inc. NY	105,000	$1.59M	0.0%	N/A	0.015%
11/17/2025	Bank of America Corp DE	2,687,805	$40.67M	0.0%	+1.3%	0.394%
11/17/2025	Alliancebernstein L.P.	556,803	$8.42M	0.0%	+2.7%	0.082%
11/17/2025	Ameriprise Financial Inc.	448,361	$6.78M	0.0%	-3.2%	0.066%
11/14/2025	Schonfeld Strategic Advisors LLC	178,965	$2.71M	0.0%	+1,053.6%	0.026%
11/14/2025	Creative Planning	65,352	$0.99M	0.0%	+24.4%	0.010%
11/14/2025	Viking Global Investors LP	23,594,831	$356.99M	0.9%	-31.1%	3.455%
11/14/2025	SummitTX Capital L.P.	105,083	$1.59M	0.1%	+70.0%	0.015%
11/14/2025	Raymond James Financial Inc.	24,637	$0.37M	0.0%	+12.1%	0.004%
11/14/2025	Virtu Financial LLC	12,423	$0.19M	0.0%	N/A	0.002%
11/14/2025	Amundi	32,416	$0.53M	0.0%	-92.0%	0.005%
11/14/2025	Rubric Capital Management LP	20,000,000	$302.60M	3.4%	-1.8%	2.929%
11/14/2025	Man Group plc	484,154	$7.33M	0.0%	+217.5%	0.071%
11/14/2025	Orbimed Advisors LLC	2,714,798	$41.08M	1.0%	-2.3%	0.398%
11/14/2025	ADAR1 Capital Management LLC	3,347,501	$50.65M	4.8%	+72.5%	0.490%
11/14/2025	Brooklyn Investment Group	20,414	$0.31M	0.0%	+30.1%	0.003%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	2,123,617	$32.13M	0.0%	-23.5%	0.311%
11/14/2025	Tower Research Capital LLC TRC	34,497	$0.52M	0.0%	+55.9%	0.005%
11/14/2025	Vident Advisory LLC	25,596	$0.39M	0.0%	-2.6%	0.004%
11/14/2025	Squarepoint Ops LLC	1,433,029	$21.68M	0.0%	-35.2%	0.210%
11/14/2025	Prosight Management LP	1,335,500	$20.21M	4.7%	-26.2%	0.196%

Data available starting January 2016

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.

Today's Range

Now: $21.97

$21.70

$22.22

50 Day Range

MA: $21.95

$20.10

$23.81

52 Week Range

Now: $21.97

$8.73

$23.91

Volume

4,255,113 shs

Average Volume

5,513,435 shs

Market Capitalization

$15.28 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Roivant Sciences?: Roivant Sciences' top insider shareholders include:
Sciences Ltd Roivant (Director)
Vivek Ramaswamy (Major Shareholder)
Financial Lp Qvt (Director)
Mayukh Sukhatme (Insider)
Mayukh Sukhatme (CIO)
Daniel Allen Gold (Director)
Matthew Gline (CEO)
Eric Venker (CEO)
Eric Venker (COO)
Keith S Manchester (Director)
Richard Pulik (CFO)
Rakhi Kumar (CAO)
Learn More about top insider investors at Roivant Sciences.
Who are the major institutional investors of Roivant Sciences?: Roivant Sciences' top institutional investors include:
Vanguard Group Inc. — 6.05%
UBS Group AG — 2.64%
Assenagon Asset Management S.A. — 1.00%
Jennison Associates LLC — 0.34%
Pictet Asset Management Holding SA — 0.33%
Penn Davis Mcfarland Inc. — 0.27%
Learn More about top institutional investors of Roivant Sciences stock.
Which major investors are selling Roivant Sciences stock?: During the previous quarter, ROIV stock was sold by these institutional investors:
Impax Asset Management Group plc
State of New Jersey Common Pension Fund D
Elevate Capital Advisors LLC
SG Americas Securities LLC
Penn Davis Mcfarland Inc.
State of Alaska Department of Revenue
GF Fund Management CO. LTD.
Within the last year, company insiders that have sold Roivant Sciences company stock include:
Sciences Ltd Roivant (Director)
Vivek Ramaswamy (Major Shareholder)
Financial Lp Qvt (Director)
Mayukh Sukhatme (Insider)
Mayukh Sukhatme (CIO)
Daniel Allen Gold (Director)
Matthew Gline (CEO)
Eric Venker (CEO)
Learn More investors selling Roivant Sciences stock.
Which major investors are buying Roivant Sciences stock?: During the last quarter, ROIV stock was bought by institutional investors including:
UBS Group AG
Assenagon Asset Management S.A.
Vanguard Group Inc.
Jennison Associates LLC
Pictet Asset Management Holding SA
M&T Bank Corp
Consolidated Portfolio Review Corp
Exchange Traded Concepts LLC
In the last year, these company insiders have bought Roivant Sciences stock:
Sciences Ltd Roivant (Director)
Vivek Ramaswamy (Major Shareholder)
Learn More investors buying Roivant Sciences stock.